United States · FDA National Drug Code directory
Cefdinir
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 63187-835_5fcd955c-b46e-4949-b804-f81abe9d37b6
- Product NDC
- 63187-835
- Form
- POWDER, FOR SUSPENSION
- Composition / generic term
- Cefdinir
- Labeler
- Proficient Rx LP
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20071214
- Source listing expiry
- 20261231
Source-listed ingredients
- CEFDINIR — 125 mg/5mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 BOTTLE in 1 CARTON (63187-835-00) / 100 mL in 1 BOTTLE · 63187-835-00
- 1 BOTTLE in 1 CARTON (63187-835-60) / 60 mL in 1 BOTTLE · 63187-835-60
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →